A detailed history of Sg Americas Securities, LLC transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Sg Americas Securities, LLC holds 13,409 shares of HBIO stock, worth $28,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
13,409
Holding current value
$28,695
% of portfolio
0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$2.64 - $3.54 $35,399 - $47,467
13,409 New
13,409 $36,000
Q4 2021

Feb 07, 2022

SELL
$6.37 - $8.18 $94,403 - $121,227
-14,820 Closed
0 $0
Q3 2021

Nov 01, 2021

BUY
$6.98 - $8.47 $103,443 - $125,525
14,820 New
14,820 $103,000
Q3 2020

Nov 09, 2020

SELL
$2.75 - $4.2 $57,433 - $87,717
-20,885 Closed
0 $0
Q2 2020

Jul 20, 2020

BUY
$2.12 - $3.14 $44,276 - $65,578
20,885 New
20,885 $65,000
Q3 2019

Nov 04, 2019

SELL
$1.59 - $3.47 $18,992 - $41,449
-11,945 Closed
0 $0
Q2 2019

Jul 29, 2019

BUY
$1.93 - $4.59 $23,053 - $54,827
11,945 New
11,945 $24,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.